Marie C. Hogan

10.6k citations

109 papers · 5.8k indexed · 3 hit papers · h-index 40

Genetics top 0.2%
Molecular Biology top 2%
Nephrology top 0.2%
Pathology and Forensic Medicine top 1%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Vicente E. Torres Peter C. Harris Fernando C. Fervenza Christopher J. Ward María V. Irazabal Ulrich Specks Arlene B. Chapman Sandro Rossetti
Topics: Genetic and Kidney Cyst Diseases (60 papers)Renal Diseases and Glomerulopathies (29 papers)Renal and related cancers (20 papers)
Cited by: Nephrology Genetics Pathology and Forensic Medicine
Journals: New England Journal of Medicine Nature GeneticsSHILAP Revista de lepidopterología
Partner nations: United States Netherlands Ireland

In The Last Decade

Marie C. Hogan

104 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

2002 525 citations Christopher J. Ward, Marie C. Hogan et al. profile →
Imaging Classification of Autosomal Dominant Polycystic Kidney Disease

2014 407 citations María V. Irazabal, Eric J. Bergstralh et al. Journal of the American Society of Nephrology profile →
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

2014 340 citations Robert W. Schrier, Ronald D. Perrone et al. profile →

Peers

Countries citing papers authored by Marie C. Hogan

Since Specialization

Citations

This map shows the geographic impact of Marie C. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie C. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie C. Hogan more than expected).

Fields of papers citing papers by Marie C. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie C. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie C. Hogan. The network helps show where Marie C. Hogan may publish in the future.

Co-authorship network of co-authors of Marie C. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Marie C. Hogan. A scholar is included among the top collaborators of Marie C. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie C. Hogan. Marie C. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep Learning-Based Instance-Level Segmentation of Kidney and Liver Cysts in Computed Tomography Images of Patients Affected by Polycystic Kidney Disease 2025 ·Kidney360 ·Adriana Gregory,Mahmoud A. Khalifa,J G Im,(unknown),(unknown),(unknown),Hana Yang,Aleksandar Đenić,Andrew D. Rule,Fouad T. Chebib,Neera K. Dahl,Marie C. Hogan,Peter C. Harris,Vicente E. Torres,Bradley J. Erickson,Theodora A. Potretzke,Timothy L. Kline	0
2	Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy 2023 ·HPB ·Thijs R.M. Barten,(unknown),Marie C. Hogan,Tom J.G. Gevers,Joost P.H. Drenth	2
3	Examining the safety and effectiveness of a 4-week supervised exercise intervention in the treatment of frailty in patients with chronic kidney disease 2023 ·Clinical Kidney Journal ·Elizabeth C. Lorenz,LaTonya J. Hickson,Marie C. Hogan,Cassie C. Kennedy	4
4	Identification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient Selection 2021 ·Mayo Clinic Proceedings ·Jing Miao,Filippo Pinto e Vairo,Marie C. Hogan,Stephen B. Erickson,Mireille El Ters,Andrew Bentall,Aleksandra Kukla,Eddie L. Greene,Loren Herrera Hernandez,Sanjeev Sethi,Konstantinos N. Lazaridis,Pavel N. Pichurin,Emily C. Lisi,(unknown),Ladan Zand,Fernando C. Fervenza	27
5	COVID-19 Vaccination and Glomerulonephritis 2021 ·Kidney International Reports ·Nattawat Klomjit,Mariam P. Alexander,Fernando C. Fervenza,Ziad Zoghby,(unknown),Marie C. Hogan,Samih H. Nasr,(unknown),Ladan Zand	134
6	Establishing a nephrology genetic clinic 2021 ·Kidney International ·Filippo Pinto e Vairo,Jennifer L. Kemppainen,John C. Lieske,Peter C. Harris,Marie C. Hogan	14
7	Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease 2020 ·Surgery ·(unknown),Myrte K. Neijenhuis,Marie E. Edwards,Jeff A. Sloan,(unknown),Rory L. Smoot,David M. Nagorney,Joost P.H. Drenth,Marie C. Hogan	10
8	Characteristics of Patients with End-Stage Kidney Disease in ADPKD 2020 ·Kidney International Reports ·(unknown),Lisa E. Vaughan,Marie E. Edwards,Sravanthi Lavu,Timothy L. Kline,Sarah R. Senum,(unknown),(unknown),María V. Irazabal,(unknown),Marie C. Hogan,Ziad Zoghby,Peter C. Harris,Vicente E. Torres,Fouad T. Chebib	16
9	The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases 2016 ·Kidney International ·Marie C. Hogan,Heather N. Reich,Peter J. Nelson,Sharon G. Adler,Daniel C. Cattran,Gerald B. Appel,Debbie S. Gipson,Matthias Kretzler,Jonathan P. Troost,John C. Lieske	44
10	Young Women With Polycystic Liver Disease Respond Best to Somatostatin Analogues: A Pooled Analysis of Individual Patient Data 2013 ·Gastroenterology ·Tom J.G. Gevers,Joanna IntHout,Anna Caroli,Piero Ruggenenti,Marie C. Hogan,Vicente E. Torres,Frederik Nevens,Joost P.H. Drenth	61
11	Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine 2013 ·Kidney International ·Marie C. Hogan,Kenneth L. Johnson,Roman M. Zenka,M. Cristine Charlesworth,Benjamin Madden,(unknown),Ann L. Oberg,Bing Huang,Alexey A. Leontovich,(unknown),Jason L. Bakeberg,Daniel McCormick,H. Robert Bergen,Christopher J. Ward	95
12	Epstein-Barr virus-associated nephrotic syndrome 2012 ·Clinical Kidney Journal ·(unknown),Sahil Khanna,Rakhee Vaidya,Sanjeev Sethi,Marie C. Hogan	12
13	Germline PKHD1 mutations are protective against colorectal cancer 2011 ·Human Genetics ·Christopher J. Ward,Yanhong Wu,Ruth Johnson,John R. Woollard,Eric J. Bergstralh,Mine Cicek,Jason L. Bakeberg,Sandro Rossetti,Christina M. Heyer,Gloria M. Petersen,Noralene M. Lindor,Stephen N. Thibodeau,Peter C. Harris,Vicente E. Torres,Marie C. Hogan,Lisa A. Boardman	22
14	Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease 2010 ·Journal of the American Society of Nephrology ·Marie C. Hogan,Tatyana V. Masyuk,(unknown),Vickie Kubly,Eric J. Bergstralh,Xujian Li,Bohyun Kim,Bernard F. King,James F. Glockner,David R. Holmes,Sandro Rossetti,Peter C. Harris,Nicholas F. LaRusso,Vicente E. Torres	237
15	Evaluation and Management of Pain in Autosomal Dominant Polycystic Kidney Disease 2010 ·Advances in Chronic Kidney Disease ·Marie C. Hogan,Suzanne M. Norby	55
16	The HALT Polycystic Kidney Disease Trials 2010 ·Clinical Journal of the American Society of Nephrology ·Arlene B. Chapman,Vicente E. Torres,Ronald D. Perrone,Theodore I. Steinman,Kyongtae T. Bae,J. Philip Miller,Dana C. Miskulin,Frederic F. Rahbari-Oskoui,Amirali Masoumi,Marie C. Hogan,Franz T. Winklhofer,William E. Braun,Paul A. Thompson,Catherine M. Meyers,(unknown),Robert W. Schrier	102
17	Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion 2008 ·Nephrology Dialysis Transplantation ·Joaquim Calado,Yves Sznajer,Daniel L. Metzger,Ana Rita,Marie C. Hogan,Antonios Kattamis,(unknown),Velibor Tasić,Johann Greil,Florian Brinkert,Markus J. Kemper,René Santer	78
18	56-Year-Old Man With Rash, Abdominal Pain, and Arthralgias 2007 ·Mayo Clinic Proceedings ·(unknown),(unknown),Marie C. Hogan	3
19	56-Year-Old Man With Rash, Abdominal Pain, and Arthralgias 2007 ·Mayo Clinic Proceedings ·(unknown),(unknown),Marie C. Hogan	2
20	Leptospirosis in the Republic of Ireland: 1985 to 1996. 1997 ·PubMed ·Marie C. Hogan,Gordon E. Pate,Samuel McConkey,D O’Flanagan,(unknown),George Mellotte	5

About Marie C. Hogan

Marie C. Hogan is a scholar working on Nephrology, Genetics and Pathology and Forensic Medicine, having authored 109 papers that have together received 5.8k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (60 papers), Renal Diseases and Glomerulopathies (29 papers) and Renal and related cancers (20 papers). The work is most often cited by research in Nephrology (1.5k citations), Genetics (3.3k citations) and Pathology and Forensic Medicine (1.1k citations). Marie C. Hogan has collaborated with scholars based in United States, Netherlands and Ireland. Frequent co-authors include Vicente E. Torres, Peter C. Harris, Fernando C. Fervenza, Christopher J. Ward, María V. Irazabal, Ulrich Specks, Arlene B. Chapman, Sandro Rossetti, Kyongtae T. Bae and Thomas J. McDonald. Their work appears in journals such as New England Journal of Medicine, Nature Genetics and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact